News in brief: Sex differences in DAPT risk after PCI; Medicinal cannabis for children with advanced cancer; Private oncology provider has $2 billion price tag

No sex differences in risks of aspirin withdrawal after PCI In  patients receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), women benefit as much as men from early aspirin withdrawal and continuation of ticagrelor therapy, a new study shows. A subgroup analysis of the TWILIGHT randomised clinical trial that involved 7119 patients undergoing ...

Already a member?

Login to keep reading.

© 2021 the limbic